In Vitro Fertilization (IVF) coverage criteria
Customize your policy alerts
Sign up for all Highmark Pennsylvania policy alerts
Know when Highmark Pennsylvania releases new policies or updates existing guidance.
Monitor payer policy activity
Form and criteria governing prior authorization and medical necessity determination for IVF services for Highmark/Blue Cross Blue Shield Delaware members; affects providers requesting IVF coverage.
No material clinical or coverage changes in this revision.
Coverage Criteria for In Vitro Fertilization (IVF)
The policy does not list any standalone exclusions beyond the specific coverage indications. However, prior authorization is required and approval depends on receipt of the completed Request for IVF Coverage questionnaire plus supporting clinical documentation. Failure to submit the completed authorization form and requested records to Medical Management and Policy (fax: 800.670.4862 or 888.236.6321) may result in no prior authorization determination and denial of coverage.
This document does not include any explicit statements that services are "not medically necessary." The guidance is framed as a set of criteria and an authorization process rather than affirmative noncoverage language.
Clinical Thresholds and Coding-relevant Criteria
Provider Submission & Prior Authorization Requirements
Prior authorization required
Prior authorization is required. Providers must submit the completed Request for IVF Coverage questionnaire and supporting clinical documentation to Claims Review/Medical Management for an IVF coverage determination.
Prior treatment expectations before IVF
Documented prior treatment trials are expected for certain indications: failed ovulation induction with oral agents or properly managed ovulation induction ± IUI cycles are prerequisites before IVF when applicable.
- PCOS: ovulation induction that does not produce follicular growth with oral agents, >2 dominant follicles routinely with oral agents, or >3 failed ovulation induction cycles.
- Unexplained infertility: no successful conception after 3 properly managed ovulation induction cycles, with or without IUI.
Required submission materials (IVF questionnaire)
Submit a completed Request for IVF Coverage questionnaire including physician and patient identifiers, brief patient history, infertility work‑up and test results, proposed treatment, signature, and any supporting clinical documentation to Medical Management for prior authorization.
- Physician name and address, patient name, Highmark BCBS DE ID#, current date, Blue Cross Blue Shield Provider ID# and signature.
- Infertility work‑up and treatments/medications/surgery to date — list tests and results, cause of infertility, and proposed treatment.
Submission requirement and denial risk
Failure to fax the completed IVF questionnaire and supporting clinical documentation to the Medical Management and Policy Department may result in no prior authorization determination and could preclude approval.
- Fax to Medical Management and Policy Department for Prior Authorization: 800.670.4862 (Delaware) or 888.236.6321.
Background and Rationale
In vitro fertilization (IVF) is used across a range of infertility etiologies. Indications addressed by the policy include advanced maternal age, diminished ovarian reserve (for example, AMH < 1.0, elevated early follicular FSH, or persistently low antral follicle counts), significant male factor infertility (such as very low total motile sperm or poor morphology), anatomic problems like bilateral tubal disease or severe pelvic adhesions, situations requiring a gestational carrier (for example after hysterectomy), couples with balanced translocations or high genetic risk who will pursue PGT, fertility preservation prior to gonadotoxic therapy, and unexplained infertility after failed ovulation induction/IUI. Use of IVF for these indications is contingent on meeting the clinical criteria and completing the required prior authorization process.
Definitions and Diagnostic Thresholds
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.